Quest Diagnostics Inc Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
Quest Diagnostics Inc (DGX) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of -0.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2026-02-26
- Quest Diagnostics Inc effective income tax rate reconciliation, tax contingency, percent for fiscal 2025 was -0.10%.
- Quest Diagnostics Inc effective income tax rate reconciliation, tax contingency, percent for fiscal 2024 was -0.20%.
- Quest Diagnostics Inc effective income tax rate reconciliation, tax contingency, percent for fiscal 2023 was -0.20%.
- Quest Diagnostics Inc effective income tax rate reconciliation, tax contingency, percent for fiscal 2016 was 0.50%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.10% 10-K · filed 2026-02-26 | |
| 2024-12-31 | -0.20% 10-K · filed 2026-02-26 | |
| 2023-12-31 | -0.20% 10-K · filed 2026-02-26 | |
| 2016-12-31 | 0.50% 10-K · filed 2017-02-22 | |
| 2015-12-31 | -0.40% 10-K · filed 2017-02-22 | |
| 2014-12-31 | -5.10% 10-K · filed 2017-02-22 | -4.90% 10-K · filed 2015-02-24 |
| 2013-12-31 | 1.50% 10-K · filed 2016-02-26 | 1.40% 10-K · filed 2015-02-24 |
| 2012-12-31 | 1.20% 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |